Did an iceberg just wallop into Scpharmaceuticals (NASDAQ:SCPH) stock? The biotech company’s shares are plunging at breakneck speed of almost 30%.
Will the FDA writing on the wall bode well for three pharmaceutical firms raring for a PDUFA nod this summer? Achaogen (NASDAQ:AKAO) complicated …
With SCPH standing before the FDA this summer and RIGL in less than two weeks’ time, two bulls are placing their bets behind these drug makers.